MedTrace Logo

Long-term Outcomes After Resection of Primary Duodenal Adenocarcinoma

NCT05134961 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 113

Last updated 2021-11-26

No results posted yet for this study

Summary

The aim of this study is to examine the long-term outcomes after curatively intended resection of duodenal adenocarcinoma.

Conditions

  • Duodenal Cancer

Interventions

PROCEDURE

Pancreaduodenectomy and possible adjuvant therapy

Adjuvant therapy was generally offered to patients with T4 or lymph node positive disease. As no national Danish guidelines exist, patients were treated based on the oncologists' preference.

Sponsors & Collaborators

  • Bispebjerg Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1999-01-01
Primary Completion
2020-08-31
Completion
2021-09-30

Countries

  • Denmark

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05134961 on ClinicalTrials.gov